| Price | $0.84 |
| Year Range | $0.53 – $2.98 |
| Market Cap | $7.9M |
| Industry | Biotechnology |
What Is Mainz Biomed’s AI Stock Analysis?
Mainz Biomed’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Mainz Biomed’s momentum in near-real time.
Mainz Biomed (MYNZ) has an AltIndex AI Score of 46/100, currently a Hold signal. The AI Score distills Mainz Biomed's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
Mainz Biomed’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of Mainz Biomed — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving MYNZ’s AI Score?
Fundamentals
Revenue for the last quarter was $290,000. This represents a decrease of 23.18% compared to the quarter before it, indicating a need for concern. Compared to the same quarter last year, there is an increase of 33.51%, suggesting positive year-over-year growth. Net income for the last quarter was $-8.3M. This is an increase of -21.48% compared to the quarter before it, which is a positive sign of growth. However, compared to the same quarter last year, there is a decrease of 60.98%, which may be a cause for concern. Ebitda for the last quarter was $-7.7M. This is an increase of -23.23% compared to the quarter before it, which is a positive sign of growth. Compared to the same quarter last year, there is an increase of -38.60%, suggesting positive year-over-year growth.
See Mainz Biomed’s earnings and insider transactions.
Technicals
Today's stock price is $0.84. This represents a decrease of 47.17% compared to a month ago, which may be concerning in the short-term. However, compared to a year ago, there is a decrease of 49.09%, which could be a cause for long-term concern. The trend is bearish. The current SMA10 is $1.24, which is lower than the previous SMA10 of $1.29. This suggests a potential downward trend in price movement. The RSI is 41.1, indicating a neutral condition.
See the full technical analysis and price prediction.
Alternative data
Mainz Biomed has an estimate of 0 visitors to their webpage. The number of visitors is down by -100% in the last couple of months, a worrisome trend as this can indicate a loss in customers.
Explore Mainz Biomed’s job postings, web traffic and app downloads.
Sentiment & social
Mainz Biomed has 8,200 followers on their Twitter page. The number of followers is down by -2% in the last couple of months, indicating a loss in interest in the company.
Track Mainz Biomed’s market sentiment.
Frequently Asked Questions: Mainz Biomed AI Stock Analysis
Mainz Biomed's AltIndex AI Score is 46/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates Mainz Biomed a Hold (46/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of Mainz Biomed — company overview, fundamentals, technicals and alternative data, with a recommendation. See the MYNZ AI Score or sign up to read the full thesis.
